in addition penbutolol does not cause any significant alterations in the biohumoral parameters of the patients treated and is ideal for combination with dihydralazine , reserpine and dihydrochlorotiazide in the treatment of more stubborn cases , making it possible to reduce the doses of the other drugs without causing bradycardia .
C0030812
penbutolol
C0428977
bradycardia